Tissue Diagnostics Market Size, Share, And Growth Report 2032

Tissue Diagnostics Market Size:

The global Tissue Diagnostics market size was worth around USD 5.58 billion in 2023 and is predicted to grow to around USD 9.84 billion by 2032 with a compound annual growth rate (CAGR) of roughly 6.5% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Tissue Diagnostics market on a global and regional level.

Request Free Sample

Tissue Diagnostics Market: Overview

Tissue diagnostics is an important diagnostic tool for detection of various pathological conditions and is considered gold standard for cancer diagnosis. Tissue is removed from patient by medical procedure and is sent to pathology laboratory for evaluation by molecular, histologic and ultrastructural examination.

The demand for tissue diagnostics market is driven by increasing incidences of cancer all over the world, increasing healthcare expenditure, favorable reimbursement policies, technological advancements, and improvement in the infrastructure for diagnosis of cancer. Also increasing aging population, growing health awareness and increasing government initiatives to create awareness are factors that boost the market growth. However, high degree of consolidation, high initial capital investment, and R&D expenses may act as restraining factors for the market growth. Growing demand for personalized medicine and

The study includes drivers and restraints for the tissue diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the tissue diagnostics market on a global as well as regional level.

Request Free Sample

In order to give the users of this report a comprehensive view on the tissue diagnostics market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the tissue diagnostics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the tissue diagnostics market on global and regional basis.

Tissue Diagnostics Market: Segmentation

The study provides a crucial view on the tissue diagnostics by segmenting the market based on product, technology, disease, end user and region. All the segments of tissue diagnostics market have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on product, the global tissue diagnostics market is bifurcated into consumables and instruments. The instruments segment is sub-segmented into tissue-processing systems, scanners, slide-staining systems and other instruments. The consumables segment is sub segmented into probes, reagents, kits, and antibodies. The consumables segment accounted for the largest market share in 2018 whereas the instruments segment is expected to grow at a highest CAGR over the forecast period. Technological advancements and consistent use of consumables attribute to the large share of the consumables product segment.

Based on technology market is segmented into special staining, digital pathology and workflow management, in situ hybridization and immunohistochemistry. The immunohistochemistry technology segment held largest market share in 2018. Increasing demand for in vitro diagnostics and availability of large number of products based on immunohistochemistry are factors that attribute to the largest market share in 2023.

The disease segment is divided into non-small cell lung cancer, prostate cancer, lymphoma, gastric cancer, breast cancer and other diseases. Breast cancer is the second leading type of cancer across the globe and increasing prevalence and awareness thus attribute to the largest market share of the breast cancer disease segment.

Based on end users the tissue diagnostics market is segmented into Contract research organizations, research laboratories, pharmaceutical companies, hospitals and others. Hospitals dominated the tissue diagnostics market in 2023 owing to large patient pool, availability of developed infrastructure and better accessibility. The research laboratory's end-user segment is expected to register rapid growth over the forecast period.

Tissue Diagnostics Market: Report Scope

Tissue Diagnostics Market: Regional Landscape

North America dominated the global tissue diagnostics market in 2023. Increasing cancer prevalence, the presence of developed R&D infrastructure, favorable reimbursement policies, and technological advancements are factors driving the market in this region. Europe was the second largest regional market. Growing research on tissue diagnosis, rise in R&D spending, presence of developed infrastructure, and increasing burden of cancer and other diseases are some of the factors that boost market growth in this region.

Latin America is expected to witness moderate growth over the forecast period. Asia Pacific region will exhibit the highest growth for the tissue diagnostics market in the coming years. Increasing geriatric population base, increasing healthcare spending and disposable income, health awareness, and infrastructure improvement are factors promoting tissue diagnostics market growth in Asia Pacific. Lack of awareness, funds, and infrastructure may attribute to slower growth in the Middle East and Africa.

Tissue Diagnostics Market: Competitive Players

Major players included in the report are

• Abbott
• Roche
• Merck
• Danaher
• Sakura Finetek Japan
• Thermo Fisher Scientific
• Abcam
• Agilent Technologies
• QIAGEN
• BD
• Sienna Cancer Diagnostics
• A. Menarini Diagnostics
• Royal Philips
• Cell Signaling Technology
• among others.

The Global Tissue Diagnostics Market is segmented as follows:

Global Tissue Diagnostics Market: By Product

• Instruments
  • Slide-staining systems
  • Scanners
  • Tissue-processing systems
  • Other instruments
• Consumables
  • Antibodies
  • Kits
  • Reagents
  • Probes

Global Tissue Diagnostics Market: By Technology

• Immunohistochemistry
• In situ hybridization
• Digital pathology
• workflow management
• Special staining

Global Tissue Diagnostics Market: By Disease

• Breast cancer
• Gastric cancer
• Lymphoma
• Prostate cancer
• Non-small cell lung cancer
• Other diseases

Global Tissue Diagnostics Market: By End User

• Hospitals
• Pharmaceutical companies
• Research laboratories
• Contract research organizations
• Other end users

Global Tissue Diagnostics Market: By Region

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa